Kalkine has a fully transformed New Avatar.

Tech, Healthcare stocks push ASX 200 to record high

By: Team Kalkine | Jul 15, 2025 | Read Time : 10 Mins
Tech, Healthcare stocks push ASX 200 to record high

Image Source : Krish Capital Pty Ltd

Index Update: The Australian equity benchmark closed higher on Tuesday, driven by gains in technology and healthcare stocks. The S&P/ASX 200 rose 59.90 points, or 0.70%, to finish at 8,630.30, marking a fresh record high. Over the last five days, the index has gained 0.46% and is currently 0.10% off its 52-week high. Ten of eleven sectors advanced, with Information Technology leading the rally, up 2.16% after recovering from recent declines.

Macro Update: Consumers stand to save AUD 1.2billion annually under a sweeping Reserve Bank of Australia proposal unveiled Tuesday, aiming to ban all surcharges on credit and debit card transactions across eftpos, Mastercard, and Visa networks. The plan also demands banks disclose hidden retailer fees and seeks to lower interchange fees, benefiting 90% of businesses. The RBA’s overhaul goes significantly further than measures previously proposed by the Albanese government.

Top Market Movers: Life360 Inc. (ASX: 360) led gains on the Australian market Tuesday, climbing 7.97% to close at AUD 35.23. Paladin Energy Ltd (ASX: PDN) followed with a 7.85% rise to AUD 7.69, while Lifestyle Communities Limited (ASX: LIC) advanced 7.71% to AUD 4.47. Among the top decliners, Pilbara Minerals Limited (ASX: PLS) fell 4.55%, Nufarm Limited (ASX: NUF) slipped 2.88%, and Sigma Healthcare Limited (ASX: SIG) dropped 2.49%.

Commodity Update: The dollar held firm on Tuesday amid trade talks and ahead of key U.S. inflation data and bank earnings. Oil prices slipped after President Trump gave Russia a 50-day deadline to end the Ukraine war or face energy sanctions. Japanese bond yields hit multi-decade highs ahead of elections. In commodities, gold dipped 0.02%, silver fell 0.74%, copper eased 0.25%, and Brent crude edged down 0.20% to USD69.06.

Our Stance: The Australian share market’s record high reflects broad-based strength, with technology and healthcare stocks leading the charge. The RBA’s proposed ban on card surcharges and push for greater fee transparency could deliver AUD 1.2 billion in consumer savings, supporting domestic spending. However, commodity softness and global macro risks, including U.S. inflation data, trade tensions, and geopolitical uncertainty, temper the outlook. While near-term momentum remains positive, a selectively optimistic approach is prudent, focusing on sectors with pricing power and exposure to structural tailwinds amid a still-fragile global environment.

In its latest trading session, the S&P/ASX 200 Index rose 59.90 points to close at 8,630.30, supported by a bullish candlestick pattern and strong trading volumes signals that reflect continued investor confidence and enthusiasm. Technically, the index remains firmly above its 21-period Simple Moving Average (SMA), reinforcing a near-term positive outlook. A key level to watch is resistance at 8,650.60. A decisive breakout above this threshold could mark a significant bullish development, potentially reshaping market sentiment and opening the door for further gains. From a broader perspective, the index’s position above the 50-period SMA on the weekly chart further solidifies its long-term bullish foundation. However, sustaining the current upward momentum hinges on the index’s ability to surpass and hold above the 8,650.60 resistance level.


Disclaimer-

This article has been prepared by Kalkine Pty Limited (ABN 34 154 808 312) (Australian financial services licence number 425376) (“Kalkine”) and its related bodies corporate authorised to provide general financial product advice. Kalkine.com.au and associated pages are published by Kalkine. Any information/advice provided in this article is general in nature and does not take into account your objectives, financial situation or needs. You should therefore consider whether the information is appropriate to your objectives, financial situation and needs before acting upon it. There may be a Product Disclosure Statement, Information Statement or other offer document for the securities or other financial products referred to in Kalkine articles. You should obtain a copy of the relevant Product Disclosure Statement, Information Statement or offer document and consider the statement or document before making any decision about whether to acquire the security or product. Please note past performance is neither an indicator nor a guarantee of future performance. You should also seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice/information in this article or on the Kalkine website. Not all investments are appropriate for all people. The information in this article and on Kalkine website has been prepared from a wide variety of sources, which Kalkine, to the best of its knowledge and belief, considers accurate. Kalkine has made every effort to ensure the reliability of information contained in its articles, newsletters and websites. All information represents our views at the date of publication and may change without notice. Kalkine does not guarantee the performance of, or returns on, any investment. To the extent permitted by law, Kalkine excludes all liability for any loss or damage arising from the use of this article, the Kalkine website and any information published on the Kalkine website (including any indirect or consequential loss, any data loss or data corruption). If the law prohibits this exclusion, Kalkine hereby limits its liability, to the extent permitted by law. Please also read our Terms & Conditions and Financial Services Guide for further information. On the date of publishing this article (referred to on the Kalkine website), employees and/or associates of Kalkine and its related entities do not hold interests in any of the securities or other financial products covered on the Kalkine website unless those persons comply with certain safeguards, procedures, and disclosures. Some of the images/music that may be used in the article are copyright to their respective owner(s). Kalkine does not claim ownership of any of the pictures displayed/music used in the article unless stated otherwise. The images/music that may be used in the article are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary. Kalkine Media Pty Ltd, an affiliate of Kalkine Pty Ltd, may have received, or be entitled to receive, financial consideration in connection with providing information about certain entity(s) covered on its website.